Annual ROA
-32.86%
+25.43%+43.63%
31 December 2023
Summary:
CytoMed Therapeutics Limited annual return on assets is currently -32.86%, with the most recent change of +25.43% (+43.63%) on 31 December 2023. During the last 3 years, it has risen by +15.82% (+32.50%). GDTC annual ROA is now at all-time high.GDTC ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDTC ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.6% | - |
| 3 y3 years | +32.5% | - |
| 5 y5 years | - | - |
GDTC ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +43.6% | ||
| 5 y | 5 years | at high | +43.6% | ||
| alltime | all time | at high | +43.6% |
CytoMed Therapeutics Limited ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -32.86%(-43.6%) | - |
| Dec 2022 | -58.29%(+71.7%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -33.94%(-30.3%) | - |
| Dec 2020 | -48.68% | - |
FAQ
- What is CytoMed Therapeutics Limited annual return on assets?
- What is the all time high annual ROA for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual ROA year-on-year change?
What is CytoMed Therapeutics Limited annual return on assets?
The current annual ROA of GDTC is -32.86%
What is the all time high annual ROA for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual return on assets is -32.86%
What is CytoMed Therapeutics Limited annual ROA year-on-year change?
Over the past year, GDTC annual return on assets has changed by +25.43% (+43.63%)